Cargando...
Developing Insulin Delivery Devices with Glucose-Responsiveness
Individuals with Type 1 and advanced Type 2 diabetes require daily insulin therapy to maintain blood glucose levels in normoglycemic ranges to prevent associated morbidity and mortality. Optimal insulin delivery should offer both precise dosing in response to real-time blood glucose levels as well a...
Guardado en:
| Publicado en: | Trends Pharmacol Sci |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7758938/ https://ncbi.nlm.nih.gov/pubmed/33250274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2020.11.002 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|